AP
ABBV icon

Americana Partners’s AbbVie ABBV Stock Holding History

Americana Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.3M Sell
267,299
-1,344
-0.5% -$289K 1.52% 16
2026
Q1 		$58.4M Sell
268,643
-2,468
-0.9% -$547K 1.52% 17
2025
Q4 		$61.9M Sell
271,111
-1,617
-0.6% -$368K 1.7% 11
2025
Q3 		$63.1M Buy
272,728
+966
+0.4% +$197K 1.9% 8
2025
Q2 		$50.4M Buy
271,762
+1,592
+0.6% +$296K 1.74% 9
2025
Q1 		$56.6M Sell
270,170
-2,049
-0.8% -$398K 2.2% 5
2024
Q4 		$48.4M Buy
272,219
+198,647
+270% +$36.5M 1.97% 6
2024
Q3 		$14.5M Buy
73,572
+2,358
+3% +$440K 0.99% 26
2024
Q2 		$12.2M Buy
71,214
+1,021
+1% +$169K 0.96% 26
2024
Q1 		$12.8M Sell
70,193
-1,632
-2% -$281K 1.07% 22
2023
Q4 		$11.2M Buy
71,825
+17,900
+33% +$2.61M 1.07% 22
2023
Q3 		$7.99M Buy
53,925
+1,800
+3% +$264K 0.86% 27
2023
Q2 		$7.02M Buy
52,125
+2,316
+5% +$340K 0.9% 27
2023
Q1 		$7.94M Buy
49,809
+13
+0% +$1.99K 1.25% 17
2022
Q4 		$8.05M Sell
49,796
-14,867
-23% -$2.28M 1.39% 16
2022
Q3 		$8.67M Buy
64,663
+18,747
+41% +$2.69M 1.55% 12
2022
Q2 		$6.91M Buy
45,916
+30,290
+194% +$4.63M 1.24% 17
2022
Q1 		$2.47M Sell
15,626
-19,150
-55% -$2.78M 0.76% 29
2021
Q4 		$4.71M Buy
34,776
+19,334
+125% +$2.28M 0.86% 30
2021
Q3 		$1.67M Buy
+15,442
New +$1.76M 0.4% 61
2020
Q2 		– Sell
-2,762
Closed -$210K – 92
2020
Q1 		$210K Buy
2,762
+2,400
+663% +$204K 0.21% 91
2019
Q4 		$32K Buy
+362
New +$30.1K 0.02% 281

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Americana Partners's ABBV Position: Q2 2026 in Review

Americana Partners reduced its AbbVie (ABBV) stake by 0.5% in Q2 2026, selling an estimated $289K and leaving 267,299 shares worth $67.3M. The position accounts for 1.52% of the portfolio, ranked #16.

Americana Partners first reported a position in ABBV in Q4 2019 and has held it in 22 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Americana Partners held 267,299 shares of AbbVie worth $67.3M as of Q2 2026.
  • Americana Partners sold 1,344 AbbVie shares in Q2 2026, an estimated $289K.
  • AbbVie made up 1.52% of Americana Partners's portfolio in Q2 2026, its #16 holding.
  • Americana Partners first reported a position in AbbVie in Q4 2019 and has held it in 22 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.